Presentation TCT 2012 TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3... Presenter: Peter Smits October 23, 2012
Presentation TCT 2012 TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial Presenter: Eberhard Grube October 23, 2012
Presentation TCT 2012 Yes: The Quantitative Threshold Should Be Lowered! Presenter: Maurice Sarano October 23, 2012
Presentation TCT 2012 Counterpulsation with SYMPHONY for Chronic Heart Failure Presenter: Robert Dowling October 23, 2012
Presentation TCT 2012 First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy Presenter: Martyn Thomas October 23, 2012
Presentation TCT 2012 LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond Presenter: Horst Sievert October 23, 2012
Presentation TCT 2012 The CV Service Line: Patients, Products, and Referrals Presenter: Howard Walpole October 23, 2012
Presentation TCT 2012 Economics of the Radial Approach: Do the Older Data Still Apply Today? Presenter: Duane Pinto October 23, 2012
Presentation TCT 2012 Balloon-Expandable vs. Self-Expanding vs. Covered Stents In Iliac Arteries: Insights from Clinical Trials and Clinical Practice Presenter: Tony Das October 23, 2012
Presentation TCT 2012 Acute Success Rates, Complication, and Long-term Stroke Risks After AF Ablation: A Critical Appraisal of a Mixed Literature Presenter: Shephal Doshi October 23, 2012